Carbapenem resistance in the Dominican Republic: clinical characteristics, genotypic profiles, and risk factors
Antimicrobial Stewardship & Healthcare Epidemiology · 2025 · 5 (1)
DOI: 10.1017/ash.2024.503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 27.01.2025. Verfasst von Ricardo Ernesto Hernández-Landa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To characterize the clinical and microbiological features of carbapenem-resistant Enterobacterales (CRE) compared to carbapenem-susceptible Enterobacterales (CSE) in the Dominican Republic (DR), and to assess risk factors associated with CRE.
Design
Retrospective case-control study.
Setting
Hospital General Plaza de la Salud, a tertiary teaching hospital in Santo Domingo, DR, from January 2015 to June 2024. Patients: Patients with CRE infections were identified from microbiology records. For each year, a matched group of CSE cases was selected at a 2.5:1 ratio. A total of 101 CRE cases and 280 CSE cases were included.
Methods
Data were collected on demographics, comorbidities, infection sources, hospital stay duration, antibiotic use, and microbiology results. Statistical analysis included univariate and multivariate logistic regression to identify independent risk factors for CRE.
Results
CRE cases showed higher prevalence of Enterobacter (36.5%) and Klebsiella (38.5%), while Escherichia predominated in CSE (65.5%). CRE patients had longer hospital stays (mean 18.7 vs 4.6 days, P < 0.001), higher ICU admission rates (34.7% vs 3.6%, P < 0.001), and increased invasive procedure use (eg central venous catheters, 36.6% vs 5.4%, P < 0.001). Key risk factors included antibiotic use (OR 3.09, P < 0.001) and ICU stay (OR 3.60, P = 0.012). The peak CRE resistance rate was 3.47% in 2022, a 64% increase from pre-pandemic levels.
Conclusions
CRE infections in the DR increased during the COVID-19 pandemic, associated with prolonged hospitalizations and critical care. Enhanced antimicrobial stewardship is essential to curb resistance.
Autor:innen und Institutionen
- Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic.
- University of Illinois at Chicago, Chicago, IL, USA.
ORCID-Profile: Ricardo Ernesto Hernández-Landa, Missel María Jiménez Cedano, Patricia Sanrregré-Oven, Alfredo J Mena Lora
Zitieren
APA
Hernández-Landa, R. E., Rojas-Fermín, R., Guzman-Marte, A., Agramonte, K. P., Jiménez Cedano, M. M., Mora-Peralta, S. A., Sanrregré-Oven, P., & Mena Lora, A. J. (2025). Carbapenem resistance in the Dominican Republic: clinical characteristics, genotypic profiles, and risk factors. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2024.503
Vancouver
Hernández-Landa RE, Rojas-Fermín R, Guzman-Marte A, Agramonte KP, Jiménez Cedano MM, Mora-Peralta SA, et al. Carbapenem resistance in the Dominican Republic: clinical characteristics, genotypic profiles, and risk factors. Antimicrobial Stewardship & Healthcare Epidemiology. 2025;5(1). doi:10.1017/ash.2024.503
BibTeX
@article{HernndezLanda2025,
author = {Hernández-Landa, Ricardo Ernesto and Rojas-Fermín, Rita and Guzman-Marte, Anel and Agramonte, Katherine Peralta and Jiménez Cedano, Missel María and Mora-Peralta, Surelly Alexandra and Sanrregré-Oven, Patricia and Mena Lora, Alfredo J},
title = {Carbapenem resistance in the Dominican Republic: clinical characteristics, genotypic profiles, and risk factors},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2025},
volume = {5},
number = {1},
doi = {10.1017/ash.2024.503}
}
EUVIMED